Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
  • Allergic Rhinitis
  • Anti-Infectives
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Hypertension
    • Thrombosis
  • Chronic Obstructive Pulmonary Disease
  • Diabetes
  • Eosinophilic Esophagitis
  • Microbiota and Probiotics
  • Multiple Myeloma
  • Multiple Sclerosis
  • Nasal Polyps
  • Neurological Disorders
  • Prurigo Nodularis
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Cardiovascular
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Aldurazyme®
    • Aldurazyme®
    • Dosing Calculator
  • Amaryl®
  • Apidra®
  • Aprovel®
  • Aubagio®
    • Aubagio®
    • Aubagio vs Ofatumumab
  • Cerezyme
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Asthma
    • Atopic Dermatitis
    • Nasal Polyps
    • Dupixent Eosinophilic Esophagitis
    • Prurigo Nodularis
  • Lantus®
  • Lemtrada®
  • Myozyme®
  • Nexviazyme
  • Plavix®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Renvela®
  • Sarclisa
    • Sarclisa
    • Sarclisa®
    • Sarclisa Kd®
    • Sarclisa Pd®
  • Soliqua®
    • Soliqua®
    • For a Peaceful Ramadan
    • SoliMix Study
    • Soli-Simplify Study
    • Soliqua®
    • Soliqua Safety®
    • Soliqua Simplicity®
    • Soliqua Guidelines®
    • Soliqua Data Set®
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Wall of Evidence
    • Toujeo T2DM
    • Toujeo T1DM
    • Toujeo Innovation
    • Toujeo for a Peaceful Ramadan
    • How to Start
    • Time-in-Range
  • Xenpozyme®
    • Xenpozyme®
    • Dose Escalation Phase of Olipudase
  • Zympass®
  • Xatral®
EVENTS
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
    SCIENCE
    • SCIENCE
    • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
    • Allergic Rhinitis
    • Anti-Infectives
    • Asthma
    • Atopic Dermatitis
    • Cardiovascular
      • Cardiovascular
      • Atherothrombosis
      • Dyslipidemia
      • Hypertension
      • Thrombosis
    • Chronic Obstructive Pulmonary Disease
    • Diabetes
    • Eosinophilic Esophagitis
    • Microbiota and Probiotics
    • Multiple Myeloma
    • Multiple Sclerosis
    • Nasal Polyps
    • Neurological Disorders
    • Prurigo Nodularis
    • Rare Diseases
    • Vaccines
      • Vaccines
      • Influenza
      • Meningitis
      • Pertussis & Polio
      • RSV
    PATIENT SUPPORT
    • PATIENT SUPPORT
    • Allergic Rhinitis
    • Atopic Dermatitis
    • Cardiovascular
    • Diabetes
      • Diabetes
      • Tools And Resources
        • Tools And Resources
        • Pre-Ramadan Assessment Tools
        • Toujeo Welcome Pack
        • Soliqua Welcome Pack
        • Clinical and economic value of SOLIQUA - Pharmacist perspective
    • Nasal Polyps
    • Rare Diseases
    PRODUCTS
    • PRODUCTS
    • Aldurazyme®
      • Aldurazyme®
      • Dosing Calculator
    • Amaryl®
    • Apidra®
    • Aprovel®
    • Aubagio®
      • Aubagio®
      • Aubagio vs Ofatumumab
    • Cerezyme
    • Clexane®
    • Depakine®
    • Dupixent®
      • Dupixent®
      • Asthma
      • Atopic Dermatitis
      • Nasal Polyps
      • Dupixent Eosinophilic Esophagitis
      • Prurigo Nodularis
    • Lantus®
    • Lemtrada®
    • Myozyme®
    • Nexviazyme
    • Plavix®
    • Praluent®
      • Praluent®
      • Praluent®
      • Praluent 300 mg
    • Renvela®
    • Sarclisa
      • Sarclisa
      • Sarclisa®
      • Sarclisa Kd®
      • Sarclisa Pd®
    • Soliqua®
      • Soliqua®
      • For a Peaceful Ramadan
      • SoliMix Study
      • Soli-Simplify Study
      • Soliqua®
      • Soliqua Safety®
      • Soliqua Simplicity®
      • Soliqua Guidelines®
      • Soliqua Data Set®
    • Tavanic®
    • Toujeo®
      • Toujeo®
      • Wall of Evidence
      • Toujeo T2DM
      • Toujeo T1DM
      • Toujeo Innovation
      • Toujeo for a Peaceful Ramadan
      • How to Start
      • Time-in-Range
    • Xenpozyme®
      • Xenpozyme®
      • Dose Escalation Phase of Olipudase
    • Zympass®
    • Xatral®
    EVENTS
  • LOGIN
  • SIGN UP
  • SEARCH
    • Home
    • Events

    Events

    Stay up to date and register for the latest events and view webinar recordings.

    Filters

    Therapeutical Areas
    Cardiovascular
    Diabetes
    Atopic Dermatitis
    Asthma
    Nasal Polyps
    Rare diseases
    Neurological Disorders
    Anti Infectives
    Allergic Rhinitis
    Type of Content
    Watch
    Listen
    Read

    World Epilepsy Day Podcast Ep. 3

    Sir Robin Murray updates us on Schizophrenia and it’s treatments

    World Epilepsy Day Podcast Ep. 2

    World Epilepsy Day Podcast Ep. 1

    GAED 2023

    Safe & Smart - Dr. Nabil

    Treating Type 2 Diabetes Today - How is it Changing?

    Safe & Smart - Dr. Khudhair

    Safe & Smart - Dr. Salah

    World Diabetes Day

    Safe & Smart - Dr. Kalra

    Cardiometabolic Approach in Diabetes Management

    1
    2
    3
    4
    5
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE | Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information: please contact: 800 MEDICAL Toll-Free Number,

    Email: medical-information.gulf@sanofi.com

    To report an adverse event: please call: +971 561747001 or

    Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact:

    Email: quality.greatergulf@sanofi.com

    MAT-AE-2100444-V5-May-23

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.